Sheaff Brock Investment Advisors LLC Sells 543 Shares of Abbott Laboratories (NYSE:ABT)

Sheaff Brock Investment Advisors LLC lessened its holdings in Abbott Laboratories (NYSE:ABT – Free Report) by 4.9% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund owned 10,468 shares of the healthcare product maker’s stock after selling 543 shares during the period. Sheaff Brock Investment Advisors LLC’s […]

Related Keywords

Canada ,Johna Jr ,Lisad Earnhardt ,Raymond James ,Mizuho Markets Americas ,Royal Bank ,Level Four Advisory Services ,Trinitypoint Wealth ,Allegheny Financial Group ,Barclays ,Sheaff Brock Investment Advisors ,Citigroup ,Securities Exchange Commission ,Financial Solutions ,Abbott Laboratories ,Free Report ,Brock Investment Advisors ,Markets Americas ,Point Wealth ,Street Financial Solutions ,Financial Group ,Four Advisory Services ,Exchange Commission ,Laboratories Stock Down ,Get Free Report ,Established Pharmaceutical Products ,Diagnostic Products ,Nutritional Products ,Abbott Laboratories Daily ,